RIO DE JANEIRO, BRAZIL - The clinical trial of CoronaVac, the vaccine developed by the Butantan Institute in partnership with biopharmaceutical company Sinovac Life Science, has reached its final stage.
According to information from the government of São Paulo and the Butantan Institute, the results will be released in the first week of December and the estimate is that Subscribe to our Premium Membership Plan. Already Subscribed? Login Here